Microtransplantation for advanced or relapsed solid tumors
Part of Cancer clinical trials.
This trial tests a new treatment called 'microtransplantation' for people with advanced or relapsed solid tumors. It aims to see if this approach can help shrink tumors or slow their growth while keeping side effects manageable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old.
- You have a solid tumor (like lung, ovarian, cervical, stomach, colorectal, sarcoma, or head and neck cancer) that has spread or come back.
- You can have more than one type of cancer.
- You are able to take care of yourself most of the day (Karnofsky score 40 or higher).
- You have tumors that can be measured on scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called JMKX005425 for people with advanced solid tumors that have a specific genetic feature called MSI-H or dMMR. If you have this feature and your cancer has not responded to other treatments, this study may offer a new option.
This trial tests a new drug called SCTB39G for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it can help shrink or control the cancer.
This early-stage trial tests whether a new drug called MST-168 can help people with advanced solid cancers (like lung, stomach, or colon cancer) that haven't responded to standard treatments. You'll receive the drug to see if it's safe and if it helps slow or stop your cancer.
This trial tests a combination of two cell-based therapies (SCTB41 and SCTB39-1) with or without standard cancer treatments for advanced solid tumors. The goal is to see if this approach helps slow or shrink tumors while being safe enough to use in patients.
This trial tests a new drug called AMT-676 in people with advanced solid tumors that have not responded to standard treatments. It may be an option for those with certain cancers like colorectal, stomach, or pancreatic cancer.
This trial tests two experimental drugs (SCTB41 and SCTB39G), given with or without standard cancer therapies, for people with advanced solid tumors that have not responded to other treatments. The goal is to see if this combination is safe and effective.
Hear when a new Advanced and Relapsed Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.